Recursion Pharmaceuticals

Executive Director, Asset Strategy Leadership

Recursion Pharmaceuticals$297K — $356K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD in life sciences or related field; expertise in drug discovery and development
  • 10+ years of biotech/pharma experience; proven strategic leadership in asset management
  • Deep expertise in small molecule therapeutics for oncology and immunology/inflammation; rare disease expertise a plus
  • Experience using computational approaches for clinical strategy and decision-making
  • Strong financial acumen; capable of engaging in cross-functional asset valuation and resource allocation
  • Exceptional executive presence; able to present complex ideas clearly to leadership and partners

Responsibilities

  • Define and drive asset strategy for oncology and immunology programs, informing go/no-go decisions
  • Translate proprietary Recursion OS and ClinTech insights into strategic advantages for drug development
  • Develop competitive narratives for portfolio assets to guide leadership and partnership discussions
  • Collaborate with functional leaders to ensure resource allocation aligns with strategic priorities
  • Promote Recursion's mindset of transforming patient lives through innovative asset advancement

Benefits

  • Comprehensive benefits package
  • Equity compensation
  • Annual performance bonus
  • Hybrid work model with office presence required
  • Work in a cutting-edge biotech environment focused on innovative science and patient impact
Full Job Description
The Impact You'll Make

As the Recursion clinical asset pipeline continues to mature through key inflection points, the advancing assets require leaders who can translate scientific complexity into strategic clarity. In the role of Executive Director, Asset Strategy Leadership, you will drive the strategic positioning of assets, ensuring that decisioning is grounded in competitive reality, differentiated by Recursion OS insights, and built to move with urgency for patient benefit. You will play a pivotal role ensuring advanced computational approaches and proprietary Recursion OS/ClinTech advantages are leveraged across the portfolio continuum, redefining traditional paradigms of drug development. Working across functional lines, you will partner with preclinical, clinical and platform teams, promoting communication, alignment and optimization of functional processes to ensure delivery of portfolio goals & transformative medicines for patients.

In this role, you will:
  • Define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation - integrating competitive positioning, mechanistic differentiation, biomarker strategy, and patient segmentation to sharpen go/no-go and prioritization decisions across the portfolio
  • Translate Recursion OS and ClinTech insights into strategic asset advantages, ensuring proprietary data and computational insights are maximally enabling for advancement of the drug discovery and development portfolio
  • Develop and pressure-test the competitive narrative for each oncology and I&I portfolio asset, building the evidence base that will inform leadership decisions, partnering discussions and investor communications
  • Partner with functional line leaders across clinical development, BD, finance and platform teams to ensure resource allocation reflects strategic conviction and supports the most impactful programs and workstreams
  • Propagate the Recursion mindset of radically changing lives by continuously raising the bar on how assets are advanced, differentiated, and delivered to patients with significant unmet need

The Team You'll Join

As an Executive Director, Asset Strategy Leadership, you will work across the asset portfolio, operating as a senior strategic partner to leaders in Clinical Development, Discovery, ClinTech, Platform and BD. The Portfolio Team is execution-minded and analytically rigorous - fluent in both science and AI - and responsible for industrializing Recursion's innovative science to advance medicines that matter. We break traditional silos, leveraging AI-powered platforms across data analysis, predictive modeling, RWE integration and patient stratification, all with the goal of optimizing asset positioning for the greatest benefit to patients.

The Experience You'll Need
  • A PhD in life sciences or related scientific discipline with deep expertise in drug discovery & development required
  • 10+ years of biotech/pharma experience with a proven track record of asset-level strategic leadership, advancing programs through clinical stage-gates with demonstrable impact on portfolio value
  • Deep expertise in the development of small molecule therapeutics for oncology and immunology/inflammation required, expertise in rare disease a bonus
  • Experience leveraging computational approaches and data-driven platforms to sharpen asset strategy and clinical decision-making
  • Proven ability to build and articulate the strategic and competitive case for clinical assets - integrating mechanistic differentiation, competitive dynamics, regulatory and market considerations.
  • Strong financial acumen; able to engage credibly on cross-functional resourcing, asset valuation, and portfolio trade-offs
  • Exceptional executive presence - able to synthesize complexity into clear, conviction-led recommendations and present with confidence to senior leadership and external partners

Working Location & Compensation:

This is an office-based, hybrid role in our New York City offices. Employees are expected to work in the office at least 50% of the time.

At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is: $297,000-$356,400. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.

#LI-EP1

About Recursion Pharmaceuticals

Recursion Pharmaceuticals is a biotechnology company that uses artificial intelligence and machine learning to discover new drugs. The company's proprietary platform combines high-throughput biology, chemistry, and image-based data with machine learning algorithms to identify new treatments for diseases. Recursion Pharmaceuticals is focused on developing treatments for rare genetic diseases, including lysosomal storage disorders, neurodegenerative diseases, and oncology. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.
Learn more about Recursion Pharmaceuticals
Size
400 employees
Market Cap
$1.3 billion
Industry
Founded
2013
NASDAQ

Similar Jobs

More Jobs at Recursion Pharmaceuticals

More Pharmaceuticals & Biotech Jobs

Find similar Executive Director, Asset Strategy Leadership jobs: